HER3-binding proteins and their uses
TW202635737APending Publication Date: 2026-09-01BEIJING TIDE PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115101439
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-16
- Filing Date
- 2026-01-14
- Publication Date
- 2026-09-01
Smart Images

Figure 00000000_0000_ABST
Abstract
This application provides HER-binding proteins and their uses. Specifically, it provides antibodies against HER3 or antigen-binding fragments thereof, nucleic acid molecules encoding them, and methods for their preparation. The HER3 antibodies or antigen-binding fragments thereof exhibit stronger binding to human HER3 protein and / or tumor cells expressing human HER3 protein compared to the positive control antibody BMK1. Further, it provides the use of the antibodies or antigen-binding fragments thereof in the treatment and diagnosis of diseases.
Need to check novelty before this filing date? Find Prior Art